Register now for the International Consortium on Newborn Sequencing on October 9 to October 10, 2024 at the New York Academy of Medicine in New York City.
ICoNS is an alliance of genomic scientists and stakeholders who share a vision of responsibly implementing newborn sequencing to predict treatable disease in babies and intervene before symptoms begin.
Our mission is to inform the clinical and public health research and implementation of genomic screening in newborns through the harmonization and aggregation of scientific evidence and resources.
We do this by promoting the exchange of ideas and encouraging an open forum for leaders in this space, establishing a common vision for newborn sequencing as a public health tool, and organizing efforts needed to advance the field.